Trademarkia Logo

Australia

AU$
HEPJUVO
Cancelled: Cancelled at the request of IB

Last updated on 28 Sept 2023

Owner Info

Intercept Pharmaceuticals, Inc.

10 Hudson Yards, 37th Floor

New York NY 10001, UNITED STATES OF AMERICA

Serial Number

2004223 filed on 11 Mar 2019

Correspondent

Cooley LLP, Karen K. Won Cooley LLP

1299 Pennsylvania Ave., N.W.,,

Suite 700,

UNITED STATES OF AMERICA

HEPJUVO

Classification Information


Class [005]
Pharmaceutical preparations, namely, therapeutic bile acid analogues; pharmaceutical preparations for the treatment of liver diseases, disorders and c Read More

Mark Details


Serial Number

2004223

Registered On

11 Mar 2019

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

23 Oct 2018

Mark Type

US

Legal History


Show more

Status DateAction Taken
28th Sept 2023Status change to Voided
9th Oct 2019International Registration in Australia Protected correspondence sent
8th Oct 2019IP Right Registration Published
8th Oct 2019Status change to Registered/Protected
29th Jul 2019Application Accepted correspondence sent
28th Jul 2019IP Right Acceptance Published
28th Jul 2019IP Right has been Examined
28th Jul 2019Status change to Accepted
23rd Apr 2019Awaiting examination
23rd Apr 2019Examination expedited